Genomics BioSci & Tech. Co.,Ltd. (TPEX: 4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.20
+0.10 (0.52%)
Dec 31, 2024, 3:00 PM CST

Genomics BioSci & Tech. Co.,Ltd. Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-158.49-168.0771.618.740.6284.94
Upgrade
Depreciation & Amortization
53.339.3732.5233.2334.8438.88
Upgrade
Other Amortization
0.770.610.460.730.370.3
Upgrade
Loss (Gain) From Sale of Assets
----65.184.04-
Upgrade
Loss (Gain) From Sale of Investments
39.0765.29-124.769.316.98-100.1
Upgrade
Loss (Gain) on Equity Investments
16.4819.5618.8813.46-2.893.05
Upgrade
Stock-Based Compensation
0.010.630.91---
Upgrade
Provision & Write-off of Bad Debts
-4.85-3.091.86-0.574.063.86
Upgrade
Other Operating Activities
43.290.19-4.87-3.73-78.04
Upgrade
Change in Accounts Receivable
26.48-0.78-20.16-6.614.98-18.56
Upgrade
Change in Inventory
-33.59-10.82-20.581.84-14.445.86
Upgrade
Change in Accounts Payable
3.34-10.7313.05-0.51-5.523.29
Upgrade
Change in Unearned Revenue
2.89-7.281.117.15-25.1438.59
Upgrade
Change in Other Net Operating Assets
-28.76-243.81-34.48-2324.46
Upgrade
Operating Cash Flow
-79.35-96.02-21.13-27.76-18.8378.34
Upgrade
Operating Cash Flow Growth
-----36.46%
Upgrade
Capital Expenditures
-208.66-150.26-94.08-93.59-42.69-20.98
Upgrade
Sale of Property, Plant & Equipment
---7.93--
Upgrade
Divestitures
----134.84--
Upgrade
Sale (Purchase) of Intangibles
-0.77-1.11-0.15-1.23-3.74-0.63
Upgrade
Investment in Securities
-19-7123.47-40.42-72.820.04
Upgrade
Other Investing Activities
-5.340.63-0.41-55.49-3.64111.43
Upgrade
Investing Cash Flow
-233.48-157.7428.83-317.64-122.8989.85
Upgrade
Short-Term Debt Issued
-5050-50-
Upgrade
Long-Term Debt Issued
-147.089035.02--
Upgrade
Total Debt Issued
299.7197.0814035.0250-
Upgrade
Short-Term Debt Repaid
--50--50--
Upgrade
Long-Term Debt Repaid
--100.32-8.16-7.2-7.06-9.12
Upgrade
Total Debt Repaid
-96.27-150.32-8.16-57.2-7.06-9.12
Upgrade
Net Debt Issued (Repaid)
203.4346.76131.84-22.1842.94-9.12
Upgrade
Issuance of Common Stock
-150.465.52---
Upgrade
Common Dividends Paid
-7.1-7.1-0-0.04-69.47-
Upgrade
Other Financing Activities
108.68--0.08243.911.62
Upgrade
Financing Cash Flow
305.01190.06197.35-22.13217.38-7.5
Upgrade
Foreign Exchange Rate Adjustments
0.32-0.274.46-1.920.15-0.32
Upgrade
Net Cash Flow
-7.5-63.97209.51-369.4575.81160.37
Upgrade
Free Cash Flow
-288.02-246.28-115.21-121.35-61.5357.36
Upgrade
Free Cash Flow Growth
-----46.57%
Upgrade
Free Cash Flow Margin
-69.06%-62.17%-27.50%-31.12%-13.88%13.41%
Upgrade
Free Cash Flow Per Share
-3.98-3.46-1.81-2.01-1.020.95
Upgrade
Cash Interest Paid
5.794.791.981.6711.05
Upgrade
Cash Income Tax Paid
0.150.810.01-2.810
Upgrade
Levered Free Cash Flow
-262.69-219.67-104.84-123.73-57.8492.72
Upgrade
Unlevered Free Cash Flow
-259.07-216.68-103.6-122.68-57.2193.38
Upgrade
Change in Net Working Capital
39.2154.7322.3143.9250.48-70.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.